Filtros de búsqueda

Lista de obras de Maria Trojano

A Case Report of Double Filtration Plasmapheresis in an Acute Episode of Multiple Sclerosis

artículo científico publicado en 2008

A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients

artículo científico publicado en 2015

A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN

artículo científico publicado en 2004

A genome screen for multiple sclerosis in Italian families.

artículo científico publicado en 2001

A rare association of anti-alanine-transfer RNA synthetase (anti-PL12) syndrome and sporadic inclusion body myositis

scientific article published on 05 August 2017

A rare case of multiple sclerosis and McArdle disease.

artículo científico publicado en 2015

A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy

article

A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis

artículo científico publicado en 2015

A systematic review of the incidence and prevalence of cancer in multiple sclerosis

artículo científico publicado en 2014

A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis

artículo científico publicado en 2014

A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview

artículo científico publicado en 2015

A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis

artículo científico publicado en 2014

A whole genome screen for linkage disequilibrium in multiple sclerosis performed in a continental Italian population

article

Acute changes in blood-CSF barrier permselectivity to serum proteins after intrathecal methotrexate and CNS irradiation

artículo científico publicado en 1985

Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone

article

Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta.

artículo científico publicado en 2003

Advances in the management of MS symptoms: real-life evidence

artículo científico publicado en 2015

Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes

artículo científico publicado en 2016

Age-related Vascular Differences among Patients Suffering from Multiple Sclerosis

scientific article published on 01 February 2014

Age-related changes of serum N-acetyl-aspartate in healthy controls

artículo científico publicado en 2011

Age-related disability in multiple sclerosis

artículo científico publicado en 2002

Age-related gadolinium-enhancement of MRI brain lesions in multiple sclerosis.

artículo científico publicado en 2005

An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care

artículo científico publicado en 2010

Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis.

artículo científico publicado en 2014

Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS.

artículo científico publicado en 2017

Anxiety and depression in multiple sclerosis patients around diagnosis

artículo científico publicado en 2011

Anxiety state affects information processing speed in patients with multiple sclerosis

artículo científico publicado en 2013

Aquaporin-4 autoantibodies in Neuromyelitis Optica: AQP4 isoform-dependent sensitivity and specificity

artículo científico publicado en 2013

Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies

artículo científico publicado en 2009

Assessing response to interferon-β in a multicenter dataset of patients with MS.

artículo científico publicado en 2016

Association between Synapsin III gene promoter polymorphisms and multiple sclerosis

artículo científico publicado en 2004

Atypical forms of multiple sclerosis or different phases of a same disease?

artículo científico publicado en 2004

BREMSO: a simple score to predict early the natural course of multiple sclerosis.

artículo científico publicado en 2015

Benign multiple sclerosis

artículo científico publicado en 2006

Brainstem PML lesion mimicking MS plaque in a natalizumab-treated MS patient.

artículo científico publicado en 2013

Breastfeeding is not related to postpartum relapses in multiple sclerosis

artículo científico publicado en 2011

CD45 and multiple sclerosis: the exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers

artículo científico publicado en 2003

COGNITIVE AND PSYCHOSOCIAL FEATURES OF CHILDHOOD AND JUVENILE MS

artículo científico publicado en 2009

Can databasing optimise patient care?

artículo científico publicado en 2004

Caregiver quality of life in multiple sclerosis: a multicentre Italian study.

artículo científico publicado en 2007

Cerebral cortex demyelination and oligodendrocyte precursor response to experimental autoimmune encephalomyelitis.

artículo científico publicado en 2011

Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis.

artículo científico publicado en 2017

Cerebrospinal fluid neurofilament tracks fMRI correlates of attention at the first attack of multiple sclerosis

scientific article published on 28 August 2014

Changes in magnetic resonance imaging disease measures over 3 years in mildly disabled patients with relapsing-remitting multiple sclerosis receiving interferon β-1a in the COGnitive Impairment in MUltiple Sclerosis (COGIMUS) study

artículo científico publicado en 2011

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.

artículo científico publicado en 2017

Clinical case reviews and poster sessions in multiple sclerosis spasticity: main outcomes and highlights.

artículo científico publicado en 2014

Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica

artículo científico publicado en 2004

Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis.

artículo científico publicado en 2006

Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.

artículo científico publicado en 2008

Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease

artículo científico publicado en 2017

Communicating the diagnosis of multiple sclerosis - a qualitative study

scientific article published on 15 March 2007

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

artículo científico publicado en 2014

Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.

artículo científico publicado en 2016

Comparative efficacy of switching to natalizumab in active multiple sclerosis

artículo científico publicado en 2015

Comparison of clinical and demographic features between affected pairs of Italian multiple sclerosis multiplex families; relation to tumour necrosis factor genomic polymorphisms.

artículo científico publicado en 1999

Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis

artículo científico publicado en 2015

Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial.

artículo científico publicado en 2013

Contribution of different relapse phenotypes to disability in multiple sclerosis.

artículo científico publicado en 2016

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

artículo científico publicado en 2015

Correction to: Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach

artículo científico publicado en 2017

Country, sex, EDSS change and therapy choice independently predict treatment discontinuation in multiple sclerosis and clinically isolated syndrome

artículo científico publicado en 2012

Defining reliable disability outcomes in multiple sclerosis.

artículo científico publicado en 2015

Defining secondary progressive multiple sclerosis

artículo científico publicado en 2016

Development of an Aquaporin-4 Orthogonal Array of Particle-Based ELISA for Neuromyelitis Optica Autoantibodies Detection

artículo científico publicado en 2015

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

artículo científico publicado en 2017

Differential Regulation of Membrane Bound and Soluble ICAM 1 in Human Endothelium and Blood Mononuclear Cells: Effects of Interferon Beta-1a

artículo científico publicado en 2002

Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: a propensity score-matched study

artículo científico publicado en 2016

Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-beta

artículo científico publicado en 2005

Dopaminergic Modulation of CD4+CD25high Regulatory T Lymphocytes in Multiple Sclerosis Patients during Interferon-ß Therapy

artículo científico publicado en 2012

Early prediction of the long term evolution of multiple sclerosis: the Bayesian Risk Estimate for Multiple Sclerosis (BREMS) score.

artículo científico publicado en 2007

Effectiveness and Tolerability of THC/CBD Oromucosal Spray for Multiple Sclerosis Spasticity in Italy: First Data from a Large Observational Study.

artículo científico publicado en 2015

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity

artículo científico publicado en 2016

Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results.

artículo científico publicado en 2014

Elevated plasma homocysteine levels in patients with multiple sclerosis are associated with male gender

scientific article published on 16 March 2012

Emotional and neutral verbal memory impairment in Multiple Sclerosis

artículo científico publicado en 2014

Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study.

artículo científico publicado en 2012

Epoch Analysis of On-Treatment Disability Progression Events over Time in the Tysabri Observational Program (TOP)

artículo científico publicado en 2016

Erratum to: Guidelines on the clinical use for the detection of neutralizing antibodies (NAbs) to IFN beta in multiple sclerosis therapy: report from the Italian Multiple Sclerosis Study group

article

European validation of a standardized clinical description of multiple sclerosis

artículo científico publicado en 2004

Exploratory analysis of predictors of patient adherence to subcutaneous interferon beta-1a in multiple sclerosis: TRACER study

artículo científico publicado en 2016

Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis

artículo científico publicado en 2015

First evidence of in vivo pro-angiogenic activity of cerebrospinal fluid samples from multiple sclerosis patients

article

Fluctuations of MS births and UV-light exposure.

artículo científico publicado en 2012

Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study.

artículo científico publicado en 2008

Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort.

artículo científico publicado en 2017

Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis.

artículo científico publicado en 2004

Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients

artículo científico publicado en 2003

Geographical variations in sex ratio trends over time in multiple sclerosis.

artículo científico publicado en 2012

Glatiramer acetate in multiple sclerosis: a review.

artículo científico publicado en 2007

Glatiramer acetate induces pro-apoptotic mechanisms involving Bcl-2, Bax and Cyt-c in peripheral lymphocytes from multiple sclerosis patients

artículo científico publicado en 2005

Greater sensitivity to multiple sclerosis disability worsening and progression events using a roving versus a fixed reference value in a prospective cohort study

artículo científico publicado en 2017

Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients

artículo científico publicado en 2013

Heterogeneous models for blood-cerebrospinal fluid barrier permeability to serum proteins in normal and abnormal cerebrospinal fluid/serum protein concentration gradients

artículo científico publicado en 1984

Higher latitude is significantly associated with an earlier age of disease onset in multiple sclerosis.

artículo científico publicado en 2016

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

artículo científico publicado en 2016

History of multiple sclerosis in 2 successive pregnancies: A French and Italian cohort.

artículo científico publicado en 2016

IFN-beta1a modulates the expression of CTLA-4 and CD28 splice variants in human mononuclear cells: induction of soluble isoforms

artículo científico publicado en 2001

Illness Perception and Well-Being Among Persons with Multiple Sclerosis and Their Caregivers

artículo científico publicado en 2015

Illness perceptions and psychological adjustment among persons with multiple sclerosis: the mediating role of coping strategies and social support

artículo científico publicado en 2019

Immunomodulatory properties of increased levels of liver X receptor β in peripheral blood mononuclear cells from multiple sclerosis patients

scientific article published on 24 January 2007

Immunomodulatory therapies delay disease progression in multiple sclerosis

artículo científico publicado en 2012

Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study

artículo científico publicado en 2012

Increasing age at disability milestones among MS patients in the MSBase Registry

artículo científico

Inhibition of protein kinase C counteracts TNFα-induced intercellular adhesion molecule 1 expression and fluid phase endocytosis on brain microvascular endothelial cells

artículo científico publicado en 2000

Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy

artículo científico publicado en 2003

Interferon beta-1a counteracts effects of activation on the expression of G-protein-coupled receptor kinases 2 and 3, beta-arrestin-1, and regulators of G-protein signalling 2 and 16 in human mononuclear leukocytes.

artículo científico publicado en 2002

Interferon β-1a downregulates TNFα-induced intercellular adhesion molecule 1 expression on brain microvascular endothelial cells through a tyrosine kinase-dependent pathway

artículo científico publicado en 2000

Intrathecal IgG synthesis in multiple sclerosis: Comparison between isoelectric focusing and quantitative estimation of cerebrospinal fluid IgG

artículo científico publicado en 1981

Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis

artículo científico publicado en 2002

Is it time to use observational data to estimate treatment effectiveness in multiple sclerosis?

artículo científico publicado en 2007

Isoelectric focusing and quantitative estimation of cerebrospinal fluid and serum IgG in idiopathic polyneuropathy.

artículo científico publicado en 1980

Italian Multiple Sclerosis Database Network

article

Italian studies on early-onset multiple sclerosis: the present and the future.

artículo científico publicado en 2004

LFA-1 expression on CD4(+)CD45RO(+) peripheral blood T-lymphocytes in RR MS: effects induced by rIFNbeta-1a.

artículo científico publicado en 2001

Linkage analysis of multiple sclerosis with candidate region markers in Sardinian and Continental Italian families

article

Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans

artículo científico publicado en 2006

Load-dependent dysfunction of the putamen during attentional processing in patients with clinically isolated syndrome suggestive of multiple sclerosis.

artículo científico publicado en 2013

Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients.

artículo científico publicado en 2015

Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study.

artículo científico publicado en 2015

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

artículo científico publicado en 2017

Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience.

artículo científico publicado en 2009

Longitudinal changes in social functioning in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study (II).

artículo científico publicado en 2011

Low serum urate levels are associated to female gender in multiple sclerosis patients.

artículo científico publicado en 2012

Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients.

artículo científico publicado en 2016

MS and related disorders: looking for markers of phenotypes

artículo científico publicado en 2015

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

artículo científico publicado en 2015

Management of pregnancy-related issues in multiple sclerosis patients: the need for an interdisciplinary approach

artículo científico publicado en 2017

Managing the transition (ManTra): a resource for persons with secondary progressive multiple sclerosis and their health professionals: protocol for a mixed-methods study in Italy

artículo científico publicado en 2017

Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis

scientific article published on 26 February 2012

Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.

artículo científico publicado en 2005

Multiple sclerosis in 2017: Progress in multiple sclerosis - from diagnosis to therapy

artículo científico publicado en 2018

Multiple sclerosis in Italy: cost-of-illness study

artículo científico publicado en 2011

Multiple sclerosis registries in Europe – results of a systematic survey

artículo científico publicado en 2014

Multiple sclerosis spasticity symptoms management. Endocannabinoid system modulator data beyond clinical trials

artículo científico publicado en 2013

Natalizumab discontinuation and disease restart in pregnancy: a case series.

artículo científico publicado en 2015

Natalizumab discontinuation is associated with a rebound of cognitive impairment in multiple sclerosis patients

artículo científico publicado en 2016

Natalizumab reduces serum pro-angiogenic activity in MS patients

artículo científico publicado en 2018

Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group—Italian Neurological Society

article

Neurofilament ELISA validation.

artículo científico publicado en 2009

Neuropsychological features in childhood and juvenile multiple sclerosis: Five-year follow-up

artículo científico publicado en 2014

Neutralizing and Binding Antibodies to Interferon Beta in Patients with Multiple Sclerosis: A Comparison of Assay Results from Three Italian Centres

article

New natural history of interferon-β-treated relapsing multiple sclerosis

artículo científico publicado en 2007

No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study).

artículo científico publicado en 2015

Osteopontin gene haplotypes correlate with multiple sclerosis development and progression

scientific article published on 25 April 2005

Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study

artículo científico publicado en 2014

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

artículo científico publicado en 2013

Pharmacodynamics of interferon beta in multiple sclerosis patients with or without serum neutralizing antibodies

artículo científico publicado en 2007

Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment.

artículo científico publicado en 2009

Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs

artículo científico publicado en 2014

Predictors and dynamics of postpartum relapses in women with multiple sclerosis.

artículo científico publicado en 2013

Predictors of disability worsening in clinically isolated syndrome.

artículo científico publicado en 2015

Predictors of long-term disability accrual in relapse-onset multiple sclerosis

artículo científico publicado en 2016

Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study

artículo científico publicado en 2012

Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis.

artículo científico publicado en 2010

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks

artículo científico publicado en 2018

Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks

artículo científico publicado en 2018

Pregnancy, sex and hormonal factors in multiple sclerosis.

artículo científico publicado en 2014

Prognostic indicators in pediatric clinically isolated syndrome

artículo científico publicado en 2017

Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus.

artículo científico publicado en 2003

Proteomic profiling in multiple sclerosis clinical courses reveals potential biomarkers of neurodegeneration

artículo científico publicado en 2014

Quality Assurance for Cerebrospinal Fluid Protein Analysis: International Consensus by an Internet-Based Group Discussion

scientific article published on 01 March 2003

Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study

artículo científico publicado en 2011

Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.

artículo científico publicado en 2016

Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

scientific article published on 01 March 1997

Real-life impact of early interferon beta therapy in relapsing multiple sclerosis.

artículo científico publicado en 2009

Recommendations for observational studies of comorbidity in multiple sclerosis

artículo científico publicado en 2016

Refining the linkage analysis on chromosome 10 in 449 sib-pairs with multiple sclerosis

artículo científico publicado en 2003

Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis

artículo científico publicado en 2016

Risk of relapse phenotype recurrence in multiple sclerosis.

artículo científico publicado en 2014

Safety profile of Tysabri: international risk management plan.

artículo científico publicado en 2009

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent.

artículo científico publicado en 2014

Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes

artículo científico publicado en 2003

Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment

article

Serum and CSF N-acetyl aspartate levels differ in multiple sclerosis and neuromyelitis optica

artículo científico publicado en 2011

Serum levels of N-acetyl-aspartate in migraine and tension-type headache.

artículo científico publicado en 2012

Serum levels of N-acetylaspartate in Huntington's disease: preliminary results

artículo científico publicado en 2011

Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome

artículo científico publicado en 2015

Serum soluble intercellular adhesion molecule-I in MS: relation to clinical and Gd-MRI activity and to rIFN beta-Ib treatment

artículo científico publicado en 1998

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

artículo científico publicado en 2013

Subclinical Visual Involvement in Multiple Sclerosis: A Study by MRI, VEPs, Frequency-Doubling Perimetry, Standard Perimetry, and Contrast Sensitivity

scientific article published on 01 April 2005

Subcutaneous interferon beta-1a has a positive effect on cognitive performance in mildly disabled patients with relapsing—remitting multiple sclerosis: 2-year results from the COGIMUS study ⬇️

artículo científico publicado el 1 de marzo de 2009

Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study

artículo científico publicado en 2013

Supramolecular aggregation of aquaporin-4 is different in muscle and brain: correlation with tissue susceptibility in neuromyelitis optica.

artículo científico publicado en 2017

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis.

artículo científico publicado en 2015

THC:CBD Observational Study Data: Evolution of Resistant MS Spasticity and Associated Symptoms

artículo científico publicado en 2016

Tetrahydrocannabinol:Cannabidiol Oromucosal Spray for Multiple Sclerosis-Related Resistant Spasticity in Daily Practice

artículo científico publicado en 2016

The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population

artículo científico publicado en 2014

The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy

artículo científico publicado en 2016

The IFNβ treatment of multiple sclerosis (MS) in clinical practice: the experience at the MS Center of Bari, Italy

article

The Italian Multiple Sclerosis Database Network (MSDN): the risk of worsening according to IFNβ exposure in multiple sclerosis

article

The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry

The MoSt Project––More Steps in multiple sclerosis: a Delphi method consensus initiative for the evaluation of mobility management of MS patients in Italy

article

The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population

artículo científico publicado en 2006

The Use of Immunosuppressant Therapy for Multiple Sclerosis in Italy: A Multicenter Retroprospective Study.

artículo científico publicado en 2016

The challenge of comorbidity in clinical trials for multiple sclerosis

artículo científico publicado en 2016

The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this?

artículo científico publicado en 2016

The coexistence of well- and ill-being in persons with multiple sclerosis, their caregivers and health professionals.

artículo científico publicado en 2013

The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis

artículo científico publicado en 2016

The differential diagnosis of multiple sclerosis: classification and clinical features of relapsing and progressive neurological syndromes

artículo científico publicado en 2001

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

artículo científico publicado en 2015

The evolving diagnostic criteria for multiple sclerosis

artículo científico publicado en 2011

The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude

artículo científico publicado en 2011

The heritage of glatiramer acetate and its use in multiple sclerosis

article by Giancarlo Comi et al published 4 July 2016 in Multiple Sclerosis and Demyelinating Disorders

The improvement of cognitive functions is associated with a decrease of plasma Osteopontin levels in Natalizumab treated relapsing multiple sclerosis.

artículo científico publicado en 2013

The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: a systematic review

artículo científico publicado en 2014

The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review

artículo científico publicado en 2015

The prevalence of pain in multiple sclerosis: A multicenter cross-sectional study

scientific article published on 01 September 2004

The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational study.

artículo científico publicado en 2016

The use of multiple population-based data sources for estimating MS sex ratio trends over time

article

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

artículo científico publicado en 2017

Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factors

artículo científico publicado en 2020

Translational readthrough generates new astrocyte AQP4 isoforms that modulate supramolecular clustering, glial endfeet localization, and water transport.

artículo científico publicado en 2017

Treatment decisions in multiple sclerosis - insights from real-world observational studies.

artículo científico publicado en 2017

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.

artículo científico publicado en 2017

Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term results.

artículo científico publicado en 2007

Treatment of relapsing-remitting multiple sclerosis after 24 doses of natalizumab: evidence from an Italian spontaneous, prospective, and observational study (the TY-STOP Study).

artículo científico publicado en 2014

Variations of the perforin gene in patients with multiple sclerosis

article

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda